Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome - Lleo_2021_Alzheimers.Res.Ther_13_119 |
| Author(s) : Lleo A , Carmona-Iragui M , Videla L , Fernandez S , Benejam B , Pegueroles J , Barroeta I , Altuna M , Valldeneu S , Xiao MF , Xu D , Nunez-Llaves R , Querol-Vilaseca M , Sirisi S , Bejanin A , Iulita MF , Clarimon J , Blesa R , Worley P , Alcolea D , Fortea J , Belbin O |
| Ref : Alzheimers Res Ther , 13 :119 , 2021 |
| Abstract : Lleo_2021_Alzheimers.Res.Ther_13_119 |
| ESTHER : Lleo_2021_Alzheimers.Res.Ther_13_119 |
| PubMedSearch : Lleo_2021_Alzheimers.Res.Ther_13_119 |
| PubMedID: 34183050 |
| Title : Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid - Lleo_2019_Mol.Cell.Proteomics_18_546 |
| Author(s) : Lleo A , Nunez-Llaves R , Alcolea D , Chiva C , Balateu-Panos D , Colom-Cadena M , Gomez-Giro G , Munoz L , Querol-Vilaseca M , Pegueroles J , Rami L , Llado A , Molinuevo JL , Tainta M , Clarimon J , Spires-Jones T , Blesa R , Fortea J , Martinez-Lage P , Sanchez-Valle R , Sabido E , Bayes A , Belbin O |
| Ref : Mol Cell Proteomics , 18 :546 , 2019 |
| Abstract : Lleo_2019_Mol.Cell.Proteomics_18_546 |
| ESTHER : Lleo_2019_Mol.Cell.Proteomics_18_546 |
| PubMedSearch : Lleo_2019_Mol.Cell.Proteomics_18_546 |
| PubMedID: 30606734 |
| Title : Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease: An Overview of Switching Between Pharmacological Agents - Blesa_2018_Curr.Alzheimer.Res_15_964 |
| Author(s) : Blesa R , Toriyama K , Ueda K , Knox S , Grossberg G |
| Ref : Curr Alzheimer Res , 15 :964 , 2018 |
| Abstract : Blesa_2018_Curr.Alzheimer.Res_15_964 |
| ESTHER : Blesa_2018_Curr.Alzheimer.Res_15_964 |
| PubMedSearch : Blesa_2018_Curr.Alzheimer.Res_15_964 |
| PubMedID: 29895249 |
| Title : Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease - Emre_2010_CNS.Neurosci.Ther_16_246 |
| Author(s) : Emre M , Bernabei R , Blesa R , Bullock R , Cunha L , Daniels H , Dziadulewicz E , Forstl H , Frolich L , Gabryelewicz T , Levin O , Lindesay J , Martinez-Lage P , Monsch A , Tsolaki M , van Laar T |
| Ref : CNS Neurosci Ther , 16 :246 , 2010 |
| Abstract : Emre_2010_CNS.Neurosci.Ther_16_246 |
| ESTHER : Emre_2010_CNS.Neurosci.Ther_16_246 |
| PubMedSearch : Emre_2010_CNS.Neurosci.Ther_16_246 |
| PubMedID: 20370805 |
| Title : Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease - Blesa_2007_Neurology_69_S23 |
| Author(s) : Blesa R , Ballard C , Orgogozo JM , Lane R , Thomas SK |
| Ref : Neurology , 69 :S23 , 2007 |
| Abstract : Blesa_2007_Neurology_69_S23 |
| ESTHER : Blesa_2007_Neurology_69_S23 |
| PubMedSearch : Blesa_2007_Neurology_69_S23 |
| PubMedID: 17646620 |
| Title : Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease - Blesa_2006_Pharmacogenet.Genomics_16_771 |
| Author(s) : Blesa R , Bullock R , He Y , Bergman H , Gambina G , Meyer J , Rapatz G , Nagel J , Lane R |
| Ref : Pharmacogenet Genomics , 16 :771 , 2006 |
| Abstract : Blesa_2006_Pharmacogenet.Genomics_16_771 |
| ESTHER : Blesa_2006_Pharmacogenet.Genomics_16_771 |
| PubMedSearch : Blesa_2006_Pharmacogenet.Genomics_16_771 |
| PubMedID: 17047484 |
| Title : Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease - Blesa_2006_Alzheimer.Dis.Assoc.Disord_20_248 |
| Author(s) : Blesa R , Aguilar M , Casanova JP , Boada M , Martinez S , Alom J , de la Hoz CH , Sancho J , Fernandez O , Gil-Neciga E , Masso JF |
| Ref : Alzheimer Disease & Associated Disorders , 20 :248 , 2006 |
| Abstract : Blesa_2006_Alzheimer.Dis.Assoc.Disord_20_248 |
| ESTHER : Blesa_2006_Alzheimer.Dis.Assoc.Disord_20_248 |
| PubMedSearch : Blesa_2006_Alzheimer.Dis.Assoc.Disord_20_248 |
| PubMedID: 17132969 |
| Title : Noncognitive symptoms and long-term treatment expectations for Alzheimer disease - Blesa_2004_Alzheimer.Dis.Assoc.Disord_18 Suppl 1_S9 |
| Author(s) : Blesa R |
| Ref : Alzheimer Disease & Associated Disorders , 18 Suppl 1 :S9 , 2004 |
| Abstract : Blesa_2004_Alzheimer.Dis.Assoc.Disord_18 Suppl 1_S9 |
| ESTHER : Blesa_2004_Alzheimer.Dis.Assoc.Disord_18 Suppl 1_S9 |
| PubMedSearch : Blesa_2004_Alzheimer.Dis.Assoc.Disord_18 Suppl 1_S9 |
| PubMedID: 15249843 |
| Title : Galantamine provides sustained benefits in patients with 'Advanced Moderate' Alzheimer's disease for at least 12 months - Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79 |
| Author(s) : Blesa R , Davidson M , Kurz A , Reichman W , Van Baelen B , Schwalen S |
| Ref : Dementia & Geriatric Cognitive Disorders , 15 :79 , 2003 |
| Abstract : Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79 |
| ESTHER : Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79 |
| PubMedSearch : Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79 |
| PubMedID: 12566596 |
| Title : Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease - Casademont_2003_J.Neurol.Sci_206_23 |
| Author(s) : Casademont J , Miro O , Rodriguez-Santiago B , Viedma P , Blesa R , Cardellach F |
| Ref : Journal of Neurology Sci , 206 :23 , 2003 |
| Abstract : Casademont_2003_J.Neurol.Sci_206_23 |
| ESTHER : Casademont_2003_J.Neurol.Sci_206_23 |
| PubMedSearch : Casademont_2003_J.Neurol.Sci_206_23 |
| PubMedID: 12480080 |